Public Employees Retirement System of Ohio Buys New Stake in Merit Medical Systems, Inc. $MMSI

Public Employees Retirement System of Ohio bought a new stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 43,561 shares of the medical instruments supplier’s stock, valued at approximately $3,021,000.

Several other institutional investors and hedge funds also recently modified their holdings of MMSI. State Street Corp raised its stake in shares of Merit Medical Systems by 1.5% during the fourth quarter. State Street Corp now owns 2,231,048 shares of the medical instruments supplier’s stock valued at $196,645,000 after purchasing an additional 32,459 shares in the last quarter. Conestoga Capital Advisors LLC increased its stake in Merit Medical Systems by 3.9% during the 1st quarter. Conestoga Capital Advisors LLC now owns 2,167,513 shares of the medical instruments supplier’s stock valued at $149,407,000 after buying an additional 81,030 shares during the period. Fuller & Thaler Asset Management Inc. increased its stake in Merit Medical Systems by 12.7% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,077,796 shares of the medical instruments supplier’s stock valued at $183,137,000 after buying an additional 234,682 shares during the period. Wellington Management Group LLP lifted its stake in shares of Merit Medical Systems by 7.0% in the 4th quarter. Wellington Management Group LLP now owns 1,327,013 shares of the medical instruments supplier’s stock worth $116,963,000 after acquiring an additional 86,504 shares during the period. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Merit Medical Systems by 1.0% in the first quarter. Dimensional Fund Advisors LP now owns 1,237,298 shares of the medical instruments supplier’s stock valued at $85,287,000 after acquiring an additional 12,285 shares in the last quarter. Institutional investors own 99.66% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on MMSI shares. Robert W. Baird set a $98.00 target price on Merit Medical Systems in a report on Friday, July 31st. Zacks Research upgraded Merit Medical Systems from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 25th. Weiss Ratings upgraded Merit Medical Systems from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 18th. Needham & Company LLC raised their target price on Merit Medical Systems from $90.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Finally, BTIG Research reaffirmed a “buy” rating and set a $105.00 target price on shares of Merit Medical Systems in a report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $100.00.

Merit Medical Systems Trading Up 1.2%

NASDAQ MMSI opened at $89.60 on Friday. The firm’s 50 day moving average price is $81.85 and its two-hundred day moving average price is $73.22. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.79 and a current ratio of 4.20. Merit Medical Systems, Inc. has a twelve month low of $59.74 and a twelve month high of $94.75. The stock has a market cap of $5.35 billion, a price-to-earnings ratio of 37.02, a PEG ratio of 2.21 and a beta of 0.49.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Thursday, July 30th. The medical instruments supplier reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.23. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The company had revenue of $418.84 million during the quarter, compared to analyst estimates of $405.25 million. During the same quarter in the prior year, the company earned $1.01 earnings per share. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. Equities analysts anticipate that Merit Medical Systems, Inc. will post 3.84 EPS for the current year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.